As far as we know, our study is the first evidence that in those pediatric B-ALL patients with WBC over 50,000xmm3, the NK cells display a partial decrease in SAP expression regarding those patients with WBC below 50,000xmm3. The gene discussed is SH2D1A; the disease is precursor B-cell acute lymphoblastic leukemia.